Synapse

← Annals of Lymphoma

Papers in Annals of Lymphoma

Page 1 · newest first

  1. Peripheral T-cell lymphoma in older patients: a narrative review of initial and subsequent treatments and clinical outcomesAnnals of Lymphoma · 2024
  2. Anti-TIF1γ antibody positivity without inflammatory myositis leading to expedited diagnosis of synchronous Epstein-Barr virus-positive marginal zone lymphoma and colon cancer: a case reportAnnals of Lymphoma · 2024
  3. Chronic lymphocytic leukemia infiltration of a transplanted kidney successfully treated with venetoclax and obinutuzumab: a case reportAnnals of Lymphoma · 2024
  4. Relapsed mantle cell lymphoma with parenchymal central nervous system involvement successfully treated with chimeric antigen receptor T-cell therapy—a case reportAnnals of Lymphoma · 2024
  5. Pediatric Infradiaphragmatic Hodgkin’s lymphoma: a unique identityAnnals of Lymphoma · 2024
  6. Complete renal and haematological remission in a case of mantle cell lymphoma associated paraneoplastic focal segmental glomerulosclerosis with ibrutinib: a case report and review of literatureAnnals of Lymphoma · 2023
  7. Age is just a number: managing relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in older patientsAnnals of Lymphoma · 2022
  8. The gamma delta lymphomas: an Australian multi-centre case seriesAnnals of Lymphoma · 2022
  9. Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practiceAnnals of Lymphoma · 2021
  10. Reframing Burkitt lymphoma: virology not epidemiology defines clinical variantsAnnals of Lymphoma · 2021
  11. HIV-associated lymphoma—advances in clinical managementAnnals of Lymphoma · 2021
  12. Primary central nervous system lymphoma: advances in MRI and PET imagingAnnals of Lymphoma · 2021
  13. Tumor microenvironment of follicular lymphomaAnnals of Lymphoma · 2021
  14. The contribution of ebv to the pathogenesis of classical hodgkin lymphomaAnnals of Lymphoma · 2021
  15. Adult T-cell leukemia/lymphoma—pathobiology and implications for modern clinical managementAnnals of Lymphoma · 2021
  16. Genetic heterogeneity in follicular lymphomaAnnals of Lymphoma · 2021
  17. Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma—a narrative reviewAnnals of Lymphoma · 2021
  18. Narrative review of primary central nervous system lymphoma: treatment-related neurotoxicityAnnals of Lymphoma · 2021
  19. Overcoming the blood-brain barrier in primary central nervous system lymphoma: a review on new strategies to solve an old problemAnnals of Lymphoma · 2021
  20. Predicting early progression in follicular lymphomaAnnals of Lymphoma · 2021
  21. Molecular insights into the pathogenesis of follicular lymphomaAnnals of Lymphoma · 2021
  22. Overview of the current treatment strategy in extranodal NK/T-cell lymphoma: from diagnosis to recurrenceAnnals of Lymphoma · 2021
  23. Novel targeted agents for follicular lymphomaAnnals of Lymphoma · 2021
  24. Novel immunotherapy in follicular lymphoma: a narrative reviewAnnals of Lymphoma · 2021
  25. Narrative review of chronic active EBV infection—advances in clinical managementAnnals of Lymphoma · 2021
  26. Epidemiology of marginal zone lymphomaAnnals of Lymphoma · 2021
  27. Primary central nervous system lymphoma: a narrative review of ongoing clinical trials and goals for future studiesAnnals of Lymphoma · 2021
  28. Treatment of elderly patients with primary CNS lymphomaAnnals of Lymphoma · 2021
  29. Frontline management for follicular lymphoma patients: a narrative reviewAnnals of Lymphoma · 2021
  30. Biology of splenic and nodal marginal zone lymphomasAnnals of Lymphoma · 2021
  31. Antibiotic treatment for bacteria-associated extranodal marginal zone lymphomaAnnals of Lymphoma · 2021
  32. Narrative review: secondary central nervous system lymphomaAnnals of Lymphoma · 2021
  33. Pathology of extranodal marginal zone lymphoma at different anatomic sitesAnnals of Lymphoma · 2020
  34. Primary vitreoretinal lymphoma: recent advances and literature reviewAnnals of Lymphoma · 2020
  35. Present role and future perspective of PET-CT in marginal zone lymphomaAnnals of Lymphoma · 2020
  36. Prognostic factors and risk of transformation in marginal zone lymphomaAnnals of Lymphoma · 2020
  37. Targeting pathogenic mechanisms in marginal zone lymphoma: from concepts and beyondAnnals of Lymphoma · 2020
  38. A narrative review of survival normalization in non-Hodgkin lymphoma: useful for better patient counselling and an endpoint for clinical trials?Annals of Lymphoma · 2020
  39. Minimal residual disease (MRD) in mantle cell lymphomaAnnals of Lymphoma · 2020
  40. Targeting CDK4/6 in mantle cell lymphomaAnnals of Lymphoma · 2020
  41. New drugs for the management of relapsed or refractory diffuse large B-cell lymphomaAnnals of Lymphoma · 2019
  42. Front-line therapy in elderly patients with mantle cell lymphomaAnnals of Lymphoma · 2019
  43. Risk stratification and management algorithms for patients with diffuse large B-cell lymphoma and CNS involvementAnnals of Lymphoma · 2019
  44. Venetoclax for the treatment of mantle cell lymphomaAnnals of Lymphoma · 2019
  45. Mantle cell lymphoma pathology update in the 2016 WHO classificationAnnals of Lymphoma · 2019
  46. Aggressive B-cell lymphomas—from morphology to molecular pathogenesisAnnals of Lymphoma · 2019
  47. Disparities in lymphoma on the basis of race, gender, HIV status, and sexual orientationAnnals of Lymphoma · 2017
  48. Chimeric antigen receptor T cells for the treatment of lymphomaAnnals of Lymphoma · 2017
  49. Scientific rationale for immunotherapy in lymphoma and predictors of responseAnnals of Lymphoma · 2017
  50. Responses and response evaluation of immune checkpoint inhibitors in lymphomaAnnals of Lymphoma · 2017